Is a complete CLYM research report available?

No complete published report is available for Climb Bio, Inc. (CLYM) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Climb Bio, Inc. (CLYM)

NASDAQ: CLYM · USD

$12.1

-0.03 (-0.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CLYM analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	691.7M
Net income (ttm)	-52.8M
EPS (ttm)	-$0.79
Shares out	57.3M
Volume	1,799,155
Beta	0.07
Price target	$20.9	+73.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -52.8M
EPS (ttm): -$0.79
Market cap: 691.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CLYM indicators

Market & fundamental data

Available fields

184

Groups with data

Currency

USD

Showing 184 of 184 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001768446
Company name	Climb Bio, Inc.
Country	United States
Country code	US
Cusip	28658R106
Employees	29
Employees Change	11%
Employees Change Percent	61.11
Enterprise value	$550.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-08-10
Isin	US28658R1068
Last refreshed	2026-07-31
Market cap	$691.7M
Market cap category	Small-Cap
Price	$12.08
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	CLYM
Website	https://climbbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.58%
FCF yield	-7.68%
P/B ratio	3.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-52.8M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-1.8M
ROA	-21.27
Roa5y	-16.82
ROCE	-40.51
ROE	-30.92
Roe5y	-37.77
ROIC	-21.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	701.14%
Cagr3y	64.56%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$152.4M
Cash	$109.6M
Current Assets	$113.4M
Current Liabilities	$4.1M
Debt	$479,000
Debt Equity	$0
Equity	$148.1M
Liabilities	$4.3M
Long Term Assets	$39M
Long Term Liabilities	$216,000
Net Cash	$145.8M
Net Cash By Market Cap	$20.93
Net Cash Growth	-26.12%
Net Debt Equity	$-0.98
Tangible Book Value	$148.1M
Tangible Book Value Per Share	$3.1
WACC	4.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	27.86
Net Working Capital	$32,000
Quick ratio	26.91
Working Capital	$109.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.07%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	700%
200-day SMA	7.02
3Y total return	345.76%
50-day SMA	12.09
50-day SMA vs 200-day SMA	50over200
All Time High	29.69
All Time High Change	-59.31%
All Time High Date	2021-08-30
All Time Low	1.05
All Time Low Change	1,050.48%
All Time Low Date	2025-04-07
ATR	1.01
Beta	0.07
Beta1y	2.12
Beta2y	1.57
Ch YTD	202
High	12.79
High52	14.42
High52 Date	2026-07-27
High52ch	-16.2%
Low	12.04
Low52	1.36
Low52 Date	2025-08-01
Low52ch	788.24%
Ma50ch	-0.12%
Premarket Change Percent	1.4
Premarket Price	$12.28
Premarket Volume	578
Price vs 200-day SMA	72.13%
RSI	44.73
RSI Monthly	72.13
RSI Weekly	65.5
Sharpe ratio	2.56x
Sortino ratio	4.96
Total Return	-15.07%
Tr YTD	202
Tr1m	-9.58%
Tr1w	-5.33%
Tr3m	37.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	14
Analyst Count Top	10
Analyst Price Target Top	$22.29
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.22
Operating Income	$-60.1M
Price target	$20.93
Price Target Change	$73.26
Price Target Change Top	$84.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	41,428,080%
Float Percent	72.35%
Shares Insiders	0.99%
Shares Institutions	49.37%
Shares Out	57,260,523
Shares Qo Q	1.24%
Shares Yo Y	15.07%
Short Float	16.59%
Short Ratio	4.45
Short Shares	12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.1M
Adjusted OCF	-60,938,000
Average Volume	1,179,991.75x
Bv Per Share	3.1
CAPEX	$-186,000
Ch1m	-9.58
Ch1w	-5.33
Ch1y	700
Ch3m	37.59
Ch3y	345.8
Ch6m	152.7
Change	-0.25%
Change From Open	-2.5
Close	12.11
Days Gap	2.31
Depreciation Amortization	135,000
Dollar Volume	21,733,792.4
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-60.1M
EBITDA	$-59.9M
EPS	$-0.79
F Score	1
FCF	$-53.5M
FCF EV Yield	-9.71x
FCF Per Share	$-0.93
Financing CF	-16,000
Fiscal Year End	December
Founded	2,018
Investing CF	32,629,000
Iprfo	-25.14
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-05
Ma150	8.61
Ma150ch	40.29%
Ma20	12.97
Ma20ch	-6.85%
Net CF	-20,664,000
Next Earnings Date	2026-08-11
Open	12.39
Optionable	Yes
Position In Range	5.33
Post Close	12.08
Postmarket Change Percent	1.57
Postmarket Price	$12.27
Ppne	697,000
Pre Close	12.11
Price Date	2026-07-30
Ptbv Ratio	4.7
Relative Volume	1.52x
Share Based Comp	7,637,000
Tr6m	152.72%
Us State	Massachusetts
Volume	1,799,155

Climb Bio, Inc. (CLYM)

Coverage state: Market snapshot only — no published research

Generate the first CLYM analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CLYM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLYM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CLYM

Frequently asked questions